Home › Funds › Bellecapital International Ltd. › REGN

Bellecapital International Ltd. position in REGN

REGENERON PHARMACEUTICALS · Health Care

Bellecapital International Ltd. reported holding 28,462 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$21.6M, representing 3.16% of its reported portfolio and ranking #10 among its reported holdings. Bellecapital International Ltd. has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)28.46K sh
Reported value held$21.58M
Portfolio Weight3.16%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Bellecapital International Ltd.'s REGN position evolved

Bellecapital International Ltd. first disclosed a stake in REGN in Q3 2023 at 12,520 shares (US$10.3M). The position peaked in Q3 2026 at 28,462 shares, worth US$21.6M. Across 13 filings, Bellecapital International Ltd. increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 28,462 shares valued at US$21.6M — an increase of 868 shares quarter over quarter.. Notable position changes include a 44% increase in Q4 2024 (shares fell 11% over the following quarter), a 33% increase in Q2 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.52K $10.30M New
Q4 2023 13.02K $11.44M Add
Q1 2024 13.18K $12.69M Add
Q2 2024 13.37K $14.05M Add
Q3 2024 13.60K $14.29M Add
Q4 2024 19.60K $13.96M Add
Q1 2025 19.22K $12.19M Reduce
Q2 2025 25.50K $13.39M Add
Q3 2025 27.78K $15.62M Add
Q4 2025 23.11K $17.84M Reduce
Q1 2026 24.29K $18.76M Add
Q2 2026 27.59K $17.21M Add
Q3 2026 28.46K $21.58M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Bellecapital International Ltd. held REGN?

Bellecapital International Ltd. has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Bellecapital International Ltd.'s current position in REGN?

As of Q3 2026, Bellecapital International Ltd. holds 28.46K shares of REGN (REGENERON PHARMACEUTICALS), valued at $21.58M, representing 3.16% of its reported portfolio and ranking #10.

Has Bellecapital International Ltd. been buying or selling REGN?

In the latest 13F filing (Q3 2026), Bellecapital International Ltd. increased its position in REGN. The position peaked in Q3 2026 at 28.46K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.